Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial.
Nisha C DurandH G KimVishal N PatelMarion T TurnbullJason L SiegelDavid O HodgeRabih G TawkJames F MeschiaW David FreemanAbba C ZubairPublished in: Neurocritical care (2023)
Future larger randomized, placebo-controlled ICH studies are necessary to validate this study and establish the effectiveness of this therapeutic approach in the treatment of patients with ICH.
Keyphrases
- placebo controlled
- phase iii
- open label
- double blind
- phase ii
- study protocol
- clinical trial
- mesenchymal stem cells
- phase ii study
- randomized controlled trial
- liver failure
- systematic review
- bone marrow
- brain injury
- respiratory failure
- drug induced
- current status
- hepatitis b virus
- smoking cessation
- rectal cancer
- replacement therapy
- locally advanced